The safety and tolerability of asthma medications are still a concern to many asthma patients
receiving long‐term treatment. Therefore, more safety data from long‐term, controlled trials …

BACKGROUND: The Inhaled Steroid Treatment as Regular Therapy in Early Asthma
(START) study is a worldwide, randomized, prospective study to investigate early …

Fifty‐two asthmatic children aged 4 to 13 years (mean 9. 6) were enrolled in this open 12‐
month study of budesonide, 200 meg bid, administered by tube‐spacer inhaler (INHALETE® …

This study is an extended follow‐up for 24 months of a 12‐week trial to study the long‐term
clinical efficacy of low‐dose inhaled budesonide (BUD) once or twice daily in children with …

BACKGROUND: Budesonide inhalation suspension (Pulmicort Respules; AstraZeneca LP,
Wilmington, DE), a nebulized corticosteroid, was developed for use in infants and young …

BACKGROUND: Inhaled glucocorticosteroids (GCS) are the most effective long-term
controller medications for the treatment of persistent asthma. Currently, however, available …

Inhaled budesonide has been demonstrated to be effective and safe when it is used in the
prophylaxis of severe asthma in adults and school-age children but has not been studied in …

Background: Since the recognition that asthma is characterized by extensive inflammation of
the airways, the use of inhaled corticosteroids (ICSs) as controller therapy has become …

Asthma, a chronic and potentially life‐threatening disease of the airways, affects patients of
all ages. Inhaled corticosteroids (ICS) are the recommended first‐line therapy for patients …

Background and Objective: Treatments with inhaled corticosteroids yielded conflicting
results in infants with severe asthma. The purpose of this study was to assess the efficacy of …